Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting by GlobeNewsWire | Feb 24, 2024 | Globe Newswire | 0 comments Leave a ReplyCancel reply